Connect with us

Uncategorized

Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.

Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.

“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”

Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.

“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”

Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.

“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.

“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”

Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.

Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.

Genetic testing is possible via a standard blood or saliva sample.

While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.

“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”

If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.

For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.

While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.

“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”

Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.

Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.

Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.

Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.

“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”

Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.

Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.

“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.

Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.

“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”


The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.

Continue Reading

Uncategorized

Primaries prove it: In New York, pro-Israel politics are now a liability

(JTA) — A little more than a year ago, thousands showed up for the annual Paul Feig z”l Tikkun Leil Shavuot at the Marlene Meyerson JCC Manhattan, an all-night bonanza of eclectic Jewish learning. The program featured dozens of rabbis, scholars, journalists and artists. Yet the unquestioned star of the night was Ritchie Torres, the congressman from the Bronx who has become a beloved figure in the pro-Israel community.

Hundreds packed the gym to hear from Torres, with many others turned away at the door. Eventually the discussion turned to the upcoming mayoral primary that was just weeks away. Many in the crowd were alarmed by the surging popularity of Zohran Mamdani, but still skeptical that a staunchly anti-Israel lawmaker could be elected in the city with the world’s largest Jewish community outside of Israel.

Instead of reassurance, Torres, who was backing former New York Gov. Andrew Cuomo in the mayoral primary, issued a warning: If Mamdani pulled off his improbable upset, it would quickly become open season on pro-Israel Democrats like himself.

As it turned out, Torres didn’t have to worry. He won his primary race Tuesday night in a landslide, securing around 70% of the vote in New York’s 15th Congressional District against an anti-Israel challenger. But his prediction was still spot on: The primaries were a Mamdani wave, with all three of the mayor’s endorsed congressional candidates winning their primaries – and knocking off two solidly pro-Israel incumbents, Dan Goldman and Adriano Espaillat, in the process.

In November, Mamdani’s ascension to City Hall felt like a political earthquake, putting an exclamation point on the reality that being staunchly anti-Israel was no longer a road block to success in Democratic politics. Yet Tuesday’s results feel more seismic – this is the first time that incumbent congressmen have lost their seats in campaigns in which they were repeatedly attacked for being too supportive of Israel. Whatever other issues were at play in the individual races, the success of candidates with an outsized focus on criticizing the Jewish state and groups that support it – in particular, the American Israel Public Affairs Committee – sends the message that their approach is a winning strategy.

There are still plenty of districts where Democrats can win with pro-Israel positions and pro-Israel support, for example the congressional seat being vacated in Marylan by pro-Israel stalwart Steny Hoyer. Hoyer’s pick to succeed him, Adrian Boafo, won Tuesday in a crowded 24-candidate primary with major backing from AIPAC.

But suddenly, for a widening swath of the Democratic congressional caucus, backing Israel has gone from being the politically safe move to a potential career-ender.

Goldman, who won his first reelection primary with about 65% of the vote in 2024, ended up on the wrong side of a similar landslide this time around in his race against former City Comptroller Brad Lander. Espaillat, who has served in Congress for nearly a decade and is chair of the Congressional Hispanic Caucus, lost to Darializa Avila Chevalier in New York’s 13th Congressional District, which includes Upper Manhattan and parts of the Bronx.

Following Mamdani’s lead, Lander and Avila Chevalier both sought to turn their opponent’s support for Israel into a defining moral failure and painted backing from AIPAC as the dictionary definition of being in the pocket of special interests.

Lander kicked off his campaign by making clear he wouldn’t be “doing AIPAC’s bidding” and made Goldman’s support from the pro-Israel lobby group a central issue throughout the campaign. Though Lander describes himself as a liberal Zionist, he repeatedly accused Israel of committing genocide in Gaza and promised to oppose U.S. weapons sales to Israel.

Just last year, Cuomo and then-Mayor Eric Adams thought Mamdani’s stance on the Jewish state was a major political liability, so they did all they could to play up his anti-Israel bona fides in their race against him. In a sign of how quickly the political winds have shifted in New York, Goldman this spring sought to minimize his differences with Lander on Israel, noting that they both received endorsements from J Street, the dovish group that advocates for more U.S. pressure on Israel to achieve a two-state solution. Goldman, in the final debate, even offered his own criticism of AIPAC, saying the pro-Israel group “has some real problems and is harmful in many ways.”

In contrast, Espaillat took aim at Avila Chevalier on Israel. “She went to celebrate the death of innocent people in Israel right after the attack,” Espaillat said during a recent televised debate, referencing her participation in an anti-Israel rally, which the Democratic Socialists of America had promoted, the day after Hamas’ Oct. 7, 2023, attack.

Like Mamdani, Avila Chevalier’s early anti-Israel activism was a key aspect of her political biography: She was part of the Students for Justice in Palestine group during her years as an undergraduate at Columbia Univeristy and later helped organize the school’s pro-Palestinian encampment as an alumna in 2024. During the campaign, she criticized Espaillat for his response to the detainment of Columbia University encampment leader Mahmoud Khalil, whose arrest last year became a rallying point for pro-Palestinian activists.

What should really alarm the pro-Israel community, however, is that this progressive playbook contributed to victories in two very different races. In the case of Lander versus Goldman, you had two Jewish self-described Zionists running in a very Jewish district. Avila Chevalier, on the other hand, was a non-Jewish anti-Israel challenger taking on a non-Jewish incumbent with strong pro-Israel credentials in a district with relatively few Jews (at least by New York’s standards).

As Mamdani’s handpicked squad heads to Washington, the pressure on other congressional Democrats to speak out strongly against Israel and back measures such as end to U.S. arms sales will only intensify. That was clear from the election night victory speeches.

During Avila Chevalier’s speech, the crowd erupted into cheers of “Free Palestine.” She couched her victory as a rejection of funding from AIPAC, crypto and other corporate interests.

Lander promised in his victory speech to be “one of the Jewish members of Congress most willing to stand up loud for Palestinian human rights.”

“We cannot keep paying for Netanyahu’s wars with our tax dollars,” he added. “Democratic voters across the country are saying this loud and clear.”

It’s possible that Lander’s wrong and that Mamdani’s rise and coattails are an only-in-New York thing. But based on several other results this election cycle and polling in upcoming races, that hope increasingly feels like betting against the Knicks.

For the pro-Israel community, there’s at least one bright spot: At least for now, they still have Ritchie Torres.

This article originally appeared on JTA.org.

The post Primaries prove it: In New York, pro-Israel politics are now a liability appeared first on The Forward.

Continue Reading

Uncategorized

Pro-Israel Adrian Boafo beats crowded field to replace Maryland’s Steny Hoyer

(JTA) — Pro-Israel candidate Adrian Boafo won Maryland’s Democratic primary to fill longtime Rep. Steny Hoyer’s seat on Tuesday, after waging a campaign supported by the American Israel Public Affairs Committee at a time when other members of his party are disavowing the pro-Israel lobbying group.

Boafo, 32, is a state delegate who entered the contest with low name recognition. Hoyer hand-picked his former staffer, who managed some of Hoyer’s recent campaigns.

The octogenarian worked hard to get his protege past the finish line in Maryland’s 5th Congressional District, garnering the support of much of the state’s Democratic establishment and appearing in an ad for him. Hoyer, who was for decades the number two Democratic leader in the House, is a staunch Israel advocate and AIPAC ally who will retire this January after 45 years. Boafo won with 32% of the vote in the crowded Democratic field, with 68% of votes counted on Wednesday morning.

Boafo thanked his supporters and Hoyer late Tuesday night and said that he was Hoyer’s natural successor. “At first glance it might not seem obvious, but our stories are actually very similar,” he said. “Steny and I are both the sons of immigrants. We grew up believing in an America that drew our parents from across the sea.” Boafo’s parents are Ghanaian and Hoyer’s father was Danish.

His victory offered a glimmer of hope to the party’s pro-Israel wing, coming on the same night that three progressives who ran hard against AIPAC and the war in Gaza swept New York’s primaries, toppling powerful pro-Israel Democrats. Boafo sent a message that AIPAC still has the power to buoy Democratic candidates even as criticism of Israel surges in the progressive wing of the party and the Democratic electorate. The lobby, once seen as a necessary bipartisan stamp of approval, has become a stand-in for Israel’s influence on U.S. politics.

AIPAC poured $5.7 million into Boafo’s campaign through its super PAC, United Democracy Project.

Boafo pledged during the campaign to “strengthen the U.S.-Israel alliance” and “mobilize humanitarian aid for Palestinian civilians,” as well as to “ensure Israel has the security assistance it needs.” Military aid packages to Israel have increasingly divided Democrats amid the deeply unpopular wars fought by Israel in Gaza and Iran.

AIPAC celebrated Boafo’s victory on Tuesday night. “Boafo has made clear his vision to carry forward the strong pro-Israel legacy of Congressman Steny Hoyer, one of Congress’s most steadfast champions of the U.S.-Israel relationship,” the group said on X, adding that it was proud to “help ensure this seat remains represented by pro-Israel leadership.”

Boafo also benefited from crypto money. Protect Progress, a super PAC affiliated with the crypto industry, spent $5.5 million on the race largely to boost Boafo, who previously worked as a federal lobbyist for the technology firm Oracle.

The deluge of outside spending sparked a rebuke from Boafo’s opponents during the race. Candidates Harry Dunn, Quincy Bareebe and Rushern Baker teamed up to denounce the outlays last week, with Baker saying on a press call, “Special interests don’t spend money out of civic goodwill. They spend the kind of money that we see because they expect someone to work for them.”

Maryland Democratic Sen. Chris Van Hollen also criticized the spending this month and accused the pro-Israel and crypto groups of attempting to “buy this congressional seat.”

“Voters need to understand that these groups are not investing in this race out of charity,” Van Hollen said in a press conference this month. “They are spending because they believe the beneficiary of their spending — in this case, one candidate, Adrian Boafo — will be a dependable vote in support of their special interests.”

Boafo will face small business owner Chris Chaffee, the winner of the Republican primary, in November’s general election. Boafo is all but assured to win the deep-blue district.

This article originally appeared on JTA.org.

The post Pro-Israel Adrian Boafo beats crowded field to replace Maryland’s Steny Hoyer appeared first on The Forward.

Continue Reading

Uncategorized

‘Mensch of Manhattan’ Lasher wins over Bores in fight for Nadler’s seat, media projects

(New York Jewish Week) — Micah Lasher has defeated Alex Bores in the battle for retiring Rep. Jerry Nadler’s Manhattan congressional seat, according to media projections Tuesday night.

In the race for the 12th Congressional District, the most Jewish in the country, Lasher had 40,106 votes, or 39.1 percent, and Bores collected 35,822 votes, or 35 percent, with 87 percent of the ballots counted.

The crowded field in the Democratic primary also included John F. Kennedy grandson Jack Kennedy Shlossberg, public health expert Nina Schwalbe, and George Conway, a Republican-turned-Democrat and Trump antagonist. All three were trailing well behind Lasher.

During his victory speech, Lasher pointed to both his and the district’s Jewish identity.

“It is an enormous point of pride that I will be representing the most Jewish congressional district in the country,” Lasher said. “I will always stand up for our community with pride.”

He also received a loud ovation after he thanked “the rabbis and Jewish community leaders” who helped the campaign.

A number of Lasher’s political allies and former bosses spoke, including Nadler, who’s represented the upper West Side since 1992, Gov. Kathy Hochul, Comptroller Mark Levine, and Manhattan Borough President Brad Hoylman-Sigal, who told the JTA that Lasher would be a bridge between Mayor Zohran Mamdani and the Jewish community.

Holyman-Sigal called Lasher the “mensch of Manhattan.”

Lasher thanked Nadler for his decades of service and mentorship, saying he taught Lasher things like “vision, compassion, and how to canvass voters outside Zabar’s.”

Nadler is “as much an institution in Manhattan as Central Park and pastrami on rye,” Lasher said.

The House seat — which covers the Upper West and Upper East sides and midtown Manhattan, and is seen as a crown jewel in New York politics — opened up after Nadler announced last fall that he would retire at the end of this term.

Nadler’s preferred heir was Lasher, a Jewish State Assembly member who has worked for the progressive stalwart and other prominent politicians such as Gov. Kathy Hochul and former Mayor Mike Bloomberg. Lasher has the support of those former bosses, plus much of the West Side political establishment.

Fellow Assembly member Bores, meanwhile, has built a coalition that includes both pro-Israel moderates and progressive groups critical of the Jewish state by emphasizing that he will be tough on artificial intelligence companies. Former congresswoman Carolyn Maloney, who represented much of Manhattan’s East Side from 1993 until 2023, is among Bores’ supporters.

On the subject of Israel, the makeup of the NY-12 race has been unlike other contested New York City races: Elsewhere, at least one of the two leading candidates has accmused Israel of committing a genocide in Gaza and supports placing conditions on U.S. military aid to Israel.

But Lasher and Bores both describe themselves as pro-Israel and anti-Prime Minister Benjamin Netanyahu of Israel, and neither one supports blocking weapons sales to the Jewish state.

Mamdani is himself a voter in the district as a resident of Gracie Mansion and who cast his ballot a few days ago, during the early voting period, at the Metropolitan Museum of Art. He has declined to weigh in publicly on the race. The mayor endorsed two democratic socialist candidates and Brad Lander — his Jewish ally who accuses Israel of genocide, and has positioned himself against both offensive and defensive military aid to Israel — in other races.

Lasher and Bores have both consistently advocated for universally applying the existing Leahy Law, which bars the U.S. from providing military assistance to foreign military units that violate human rights with impunity.

Schlossberg has criticized Lasher and Bores for their stance, calling it an “insufficient answer,” and advocates for blocking offensive weapons sales to Israel while still funding the Iron Dome defensive missile system. He is the only of the top-four candidates to call for conditions on aid to Israel and halting any weapons sales. After initially leading in early polls, Schlossberg’s support appears to have fallen amid questions over his lack of experience.

Conway, an anti-Trumper and longtime attorney who was married to former Donald Trump staffer Kellyanne Conway, rounds out the top four in the polling.

Throughout the election, candidates convened for forums at numerous synagogues in the heavily Jewish district — 23.3% of constituents are Jewish, according to a 2024 study — and answered questions related to antisemitism, Israel and other Jewish-related issues.

Lasher has said at multiple forums that he doesn’t see anti-Zionism as being precisely the same thing as antisemitism, but that “often when you see one you see the other.”

He and Bores have both touted their support for a statewide “buffer zone” bill — which Lasher introduced in response to pro-Palestinian demonstrations outside synagogues — that would curb protests outside houses of worship. Meanwhile, Schlossberg has pointed out at Jewish forums that the first policy his campaign released was “Jack’s Fast-Track Plan,” which would fast-track a doubling of funds for the Nonprofit Security Grant Program that funds security at houses of worship and community centers.

During a June forum at Upper West Side synagogue B’nai Jeshurun, Lasher said he felt “exhausted” by how much the political dialogue — both in the NY-12 race and more broadly — is “obsessed” with Israel.

Lasher is sure to win in November’s general election in the heavily Democratic district where he will face only token Republican opposition.

The post ‘Mensch of Manhattan’ Lasher wins over Bores in fight for Nadler’s seat, media projects appeared first on The Forward.

Continue Reading

Copyright © 2017 - 2023 Jewish Post & News